Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning

Learning and Memory

Volumn 12, Issue 4, 2005, Pages 389-398

  Gould, Thomas J ^a   Lewis, Michael C ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; GLUTAMATE RECEPTOR; MECAMYLAMINE; NICOTINIC RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; FEAR; INSTRUMENTAL CONDITIONING; LATENT INHIBITION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; TASK PERFORMANCE;

ANIMALS; CONDITIONING (PSYCHOLOGY); DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; MALE; MECAMYLAMINE; MICE; MICE, INBRED C57BL; NEURAL INHIBITION; NICOTINIC ANTAGONISTS; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC;

EID: 23744514938     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.89105     Document Type: Article

References (126)

1. Alkondon, M. and Albuquerque, E.X. 2002. A non-α7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons. J. Neurophys. 87: 1651-1654.
2. Alkondon, M., Rocha, E.S., Maelicke, A., and Albuquerque, E.X. 1996. Diversity of nicotinic acetylcholine receptors in rat brain. α-bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J. Pharmacol. Exp. Ther. 278: 1460-1471.
3. Alkondon, M., Pereira, E.F.R., Barbosa, C.T.F., and Albuquerque, E.X. 1997. Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283: 1396-1411.
4. Alkondon, M., Pereira, E.F., and Albuquerque, E.X. 1998. α-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res. 810: 257-263.
5. Aramakis, V.B. and Metherate, R. 1998. Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J. Neurosci. 18: 8485-8495.
6. Attwell, P.J., Rahman, S., Ivarsson, M., and Yeo, C.H. 1999. Cerebellar cortical AMPA-kainate receptor blockade prevents performance of classically conditioned nictitating membrane responses. J. Neurosci. 19: RC45.
7. Aultman, J.M. and Moghaddam, B. 2001. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology 153: 353-364.
8. Berg, D.K. and Conroy, W.G. 2002. Nicotinic α7 receptors: Synaptic options and downstream signaling in neurons. J. Neurobiol. 53: 512-523.
9. Blanchard, R.J. and Blanchard, D.C. 1969. Passive and active reactions to fear-eliciting stimuli. J. Comp. Physiol. Psychol. 68: 129-135.
10. Bonini, J.S., Rodrigues, L., Kerr, D.S., Bevilaqua, L.R., Cammarota, M., and Izquierdo, I. 2003. AMPA/kainate and group-I metabotropic receptor antagonists infused into different brain areas impair memory formation of inhibitory avoidance in rats. Behav. Pharmacol. 14: 161-166.
11. Braff, D.L. 1993. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19: 233-259.
12. Bredt, D.S. and Nicoll, R.A. 2003. AMPA receptor trafficking at excitatory synapses. Neuron 40: 361-379.
13. Broide, R.S. and Leslie, F.M. 1999. The α7 nicotinic acetylcholine receptor in neuronal plasticity. Mol. Neurobiol. 20: 1-16.
14. Brunzell, D.H., Russell, D.S., and Picciotto, M.R. 2003. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J. Neurochem. 84: 1431-1441.
15. Burchuladze, R. and Rose, S.P. 1992. Memory formation in day-old chicks requires NMDA but not non-NMDA glutamate receptors. Eur. J. Neurosci. 4: 533-538.
16. Caldarone, B.J., Duman, C.H., and Picciotto, M.R. 2000. Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain. Neuropharmacology 39: 2779-2784.
17. Chang, K.T. and Berg, D.K. 2001. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 32: 855-865.
18. Chu, Z.G., Zhou, F.M., and Hablitz, J.J. 2000. Nicotinic acetylcholine receptor-mediated synaptic potentials in rat neocortex. Brain Res. 887: 399-405.
19. 2+ stores. J. Neurochem. 81: 606-614.
20. Dajas-Bailador, F.A., Soliakov, L., and Wonnacott, S. 2002b. Nicotine activates the extracellular signal-regulated kinase 1/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SHSY5Y cells and hippocampal neurones. J. Neurochem. 80: 520-530.
21. Danysz, W. and Wroblewski, J.T. 1989. Amnesic properties of glutamate receptor antagonists. Neurosci. Res. Commun. 479: 9-18.
22. Danysz, W., Zajaczkowski, W., and Parsons, C.G. 1995. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6: 455-474.
23. Davis, J.A. and Gould, T.J. 2005. Rolipram attenuates MK-801-induced deficits in latent inhibition. Behav. Neurosci. 119: 595-602.
24. Day, M., Langston, R., and Morris, R.G. 2003. Glutamate-receptor-mediated encoding and retrieval of paired-associate learning. Nature 424: 205-209.
25. Debray, C., Diabira, D., Gaiarsa, J.L., Ben-Ari, Y., and Gozlan, H. 1997. Contributions of AMPA and GABA(A) receptors to the induction of NMDAR-dependent LTP in CA1. Neurosci. Lett. 238: 119-122.
26. Eilers, H., Schaeffer, E., Bickler, P.E., and Forsayeth, J.R. 1997. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol. Pharmacol. 52: 1105-1112.
27. Escobar, M.L., Alcocer, I., and Bermudez-Rattoni, F. 2002. In vivo ffects of intracortical administration of NMDA and metabotropic glutamate receptors antagonists on neocortical long-term potentiation and conditioned taste aversion. Behav. Brain Res. 129: 101-106.
28. Fabian-Fine, R., Skehel, P., Errington, M.L., Davies, H.A., Sher, E., Stewart, M.G., and Fine, A. 2001. Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 21: 7339-8003.
29. Fadda, F., Cocco, S., and Stancampiano, R. 2000. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport 11: 2265-2269.
30. Fanselow, M.S. and Kim, J.J. 1994. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behav. Neurosci. 108: 210-212.
31. Fanselow, M.S., Kim, J.J., Yipp, J., and De Oca, B. 1994. Differential effects of the N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. Behav. Neurosci. 108: 235-240.
32. Filliat, P., Pernot-Marino, I., Baubichon, D., and Lallement, G. 1998. Behavioral effects of NBQX, a competitive antagonist of the AMPA receptors. Pharmacol. Biochem. Behav. 59: 1087-1092.
33. Flood, J.F., Baker, M.L., and Davis, J.L. 1990. Modulation of memory processing by glutamic acid receptor agonists and antagonists. Brain Res. 521: 197-202.
34. Frazier, C.J., Buhler, A.V., Weiner, J.L., and Dunwiddie, T.V. 1998a. Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 20: 8228-8235.
35. Frazier, C.J., Rollins, Y.D., Breese, C.R., Leonard, S., Freedman, R., and Dunwiddie, T.V. 1998b. Acetylcholine activates an α-bungarotoxin- sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18: 1187-1195.
36. Fujii, S. and Sumikawa, K. 2001. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Res. 894: 347-353.
37. Fujii, S., Ji, Z., Morita, N., and Sumikawa, K. 1999. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res. 846: 137-143.
38. Fujii, S., Jia, Y., Yang, A., and Sumikawa, K. 2000. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Res. 863: 259-265.
39. Gold, P.E. 2003. Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol. Learn. Mem. 80: 194-210.
40. Gould, T.J. 2003. Nicotine produces a within subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integ. Physiol. Behav. Sci. 38: 124-132.
41. Gould, T.J. and Higgins, J.S. 2003. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol. Learn. Mem. 80: 147-157.
42. Gould, T.J. and Lewis, M.C. 2003. Latent inhibition of cued fear conditioning is inhibited by co-antagonism of nicotinic and AMPA receptors but is not inhibited by antagonism of either receptor subtype alone. Abstract Viewer/Itinerary Planner, Program No. 721.1. Society for Neuroscience, Washington, DC.
43. Gould, T.J. and Lommock, J.A. 2003. Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning. Behav. Neurosci. 117: 1276-1282.
44. Gould, T.J. and Wehner, J.M. 1999a. Genetic influences on latent inhibition. Behav. Neurosci. 113: 1291-1296.
45. _. 1999b. Nicotine enhancement of contextual fear conditioning. Behav. Brain Res. 102: 31-39.
46. Gould, T.J., Collins, A.C., and Wehner, J.M. 2001. Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition. Nicotine Tob. Res. 3: 17-24.
47. Gould, T.J., McCarthy, M.M., and Keith, R.A. 2002. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning. Behav. Pharmacol. 13: 287-294.
48. Gould, T.J., Feiro, O., and Moore, D. 2004. Nicotine enhancement of trace cued fear conditioning but not delay cued fear conditioning in C57BL/6J mice. Behav. Brain. Res. 155: 167-173.
49. Grady, S., Marks, M.J., Wonnacott, S., and Collins, A.C. 1992. Characterization of nicotinic receptor-mediated [H-3] dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59: 848-856.
50. Gray, J.A. 1998. Integrating schizophrenia. Schizophr. Bull. 24: 249-266.
51. Gutierrez, R., De la Cruz, V., Rodriguez-Ortiz, C.J., and Bermudez-Rattoni, F. 2004. Perirhinal cortex muscarinic receptor blockade impairs taste recognition memory formation. Learn. Mem. 11: 95-101.
52. Han, J.S., Gallagher, M., and Holland, P. 1995. Hippocampal lesions disrupt decrements but not increments in conditioned stimulus processing. J. Neurosci. 15: 7323-7329.
53. Hasselmo, M.E. 1999. Neuromodulation: Acetylcholine and memory consolidation. Trends Cogn. Sci. 3: 351-359.
54. He, J., Deng, C.Y., Chen, R.Z., Zhu, X.N., and Yu, J.P. 2000. Long-term potentiation induced by nicotine in CA1 region of hippocampal slice is Ca(2+)-dependent. Acta. Pharmacol. Sin. 21: 429-432.
55. Hefft, S., Hulo, S., Bertrand, D., and Muller, D. 1999. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J. Physiol. 515: 769-776.
56. Herron, C.E., Lester, R.A., Coan, E.J., and Collingridge, G.L. 1986. Frequency-dependent involvement of NMDA receptors in the hippocampus: A novel synaptic mechanism. Nature 322: 265-268.
57. Izquierdo, L.A., Barros, D.M., Ardenghi, P.G., Pereira, P., Rodrigues, C., Choi, H., Medina, J.H., and Izquierdo, I. 2000. Different hippocampal molecular requirements for short- and long-term retrieval of one-trial avoidance learning. Behav. Brain Res. 111: 93-98.
58. Ji, D., Lape, R., and Dani, J.A. 2001. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31: 131-141.
59. Kapus, G., Szekely, J.I., Durand, J., Ruiz, A., and Tarnawa, I. 2000. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations. Brain Res. Bull. 52: 511-517.
60. Kaye, H. and Pearce, J.M. 1987. Hippocampal lesions attenuate latent inhibition and the decline of the orienting response in rats. Q. J. Exp. Psychol. B. 39: 107-125.
61. Kilts, C.D. 2001. The changing roles and targets for animal models of schizophrenia. Biol. Psych. 50: 845-855.
62. Kim, J.J. and Fanselow, M.S. 1992. Modality-specific retrograde amnesia of fear. Science 256: 675-677.
63. Kim, J.J., DeCola, J.P., Landeira-Fernandez, J., and Fanselow, M.S. 1991. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav. Neurosci. 105: 126-133.
64. Kim, M., Campeau, S., Falls, W.A., and Davis, M. 1993. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle. Behav. Neural. Biol. 59: 5-8.
65. Lees, G.J. 2000. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs 59: 33-78.
66. Lerma, J. 2003. Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 4: 481-495.
67. Levin, E.D. and Simon, B.B. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138: 217-230.
68. Levy, R.B. and Aoki, C. 2002. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22: 5001-5015.
69. Lewis, M.C. and Gould, T.J. 2004. Latent inhibition of cued fear conditioning: An NMDA receptor dependent process that can be established in the presence of anisomycin. Eur. J. Neurosci. 20: 818-826.
70. Li, H.B., Matsumoto, K., Yamamoto, M., and Watanabe, H. 1997. NMDA but not AMPA receptor antagonists impair the delay-interposed radial maze performance of rats. Pharmacol. Biochem. Behav. 58: 249-253.
71. Lisman, J. 2003. Long-term potentiation: Outstanding questions and attempted synthesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358: 829-842.
72. Logue, S.F., Paylor, R., and Wehner, J.M. 1997. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav. Neurosci. 111: 104-113.
73. Lu, Y. and Wehner, J.M. 1997. Enhancement of contextual fear-conditioning by putative (+/-)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice. Brain Res. 768: 197-207.
74. Lubow, R.E. 1989. Latent inhibition and conditional attention theory. Cambridge University Press, Cambridge, UK.
75. Lubow, R.E., Kaplan, O., Abramovich, P., Rudnick, A., and Laor, N. 2000. Visual search in schizophrenia: Latent inhibition and novel pop-out effects. Schizophr. Res. 45: 145-156.
76. Marks, M.J., Romm, E., Campbell, S.M., and Collins, A.C. 1989. Variation of nicotinic binding sites among inbred strains. Pharmacol. Biochem. Behav. 33: 679-689.
77. Matsuyama, S., Matsumoto, A., Enomoto, T., and Nishizaki, T. 2000. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur. J. Neurosci. 12: 3741-3747.
78. McGehee, D.S., Heath, M.J., Gelber, S., Devay, P., and Role, L.W. 1995. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269: 1692-1696.
79. Mead, A.N. and Stephens, D.N. 1999. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: A role for the glycine site of the NMDA receptor, but not AMPA receptors. J. Pharmacol. Exp. Ther. 290: 9-15.
80. Mesches, M.H., Bianchin, M., and McGaugh, J.L. 1996. The effects of intra-amygdala infusion of the AMPA receptor antagonist CNQX on retention performance following aversive training. Neurobiol. Learn. Mem. 66: 324-340.
81. Misztal, M. and Danysz, W. 1995. Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidance. Behav. Pharmacol. 6: 550-561.
82. Nakayama, H., Numakawa, T., Ikeuchi, T., and Hatanaka, H. 2001. Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J. Neurochem. 79: 489-498.
83. Nomikos, G.G., Schilstrom, B., Hildebrand, B.E., Panagis, G., Grenhoff, J., and Svensson, T.H. 2000. Role of α7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav. Brain Res. 113: 97-103.
84. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., and Prochiantz, A. 1984. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465.
85. Oswald, C.J., Yee, B.K., Rawlins, J.N., Bannerman, D.B., Good, M., and Honey, R.C. 2002. The influence of selective lesions to components of the hippocampal system on the orienting [correction of orientating] response, habituation and latent inhibition. Eur. J. Neurosci. 15: 1983-1990.
86. Parada, J., Czuczwar, S.J., and Turski, W.A. 1992. NBQX does not affect learning and memory tasks in mice. A comparison with d-CPPene and ifenprodil. Brain Res. Cog. Brain Res. 1: 67-71.
87. Parsons, C.G., Gruner, R., and Rozental, J. 1994. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiazepine (GYKI 52466). Neuropharmacology 33: 589-604.
88. Paylor, R., Nguyen, M., Crawley, J.N., Patrick, J., Beaudet, A., and Orr-Urtreger, A. 1998. α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice. Learn. Mem. 5: 302-316.
89. Perry, D.C., Xiao, Y., Nguyen, H.N., Musachio, J.L., Davila-Garcia, M.I., and Kellar, K.J. 2002. Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography. J. Neurochem. 82: 468-481.
90. Phillips, R.G. and LeDoux, J.E. 1992. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106: 274-285.
91. _. 1994. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn Mem. 1: 34-44.
92. Pitsikas, N., Rigamonti, A.E., Cella, S.G., and Muller, E.E. 2002. The non-NMDA receptor antagonist NBQX does not affect rats performance in the object recognition task. Pharmacol. Res. 45: 43-46.
93. Porter, J.T., Cauli, B., Tsuzuki, K., Lambolez, B., Rossier, J., and Audinat, E. 1999. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J. Neurosci. 19: 5228-5235.
94. Pouzet, B., Zhang, W.N., Weiner, I., Feldon, J., and Yee, B.K. 2004. Latent inhibition is spared by N-methyl-D-aspartate (NMDA)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral NMDA infusion. Neuroscience 124: 183-194.
95. Quillfeldt, J.A., Schmitz, P.K., Walz, R., Bianchin, M., Zanatta, M.S., Medina, J.H., and Izquierdo, I. 1994. CNQX infused into entorhinal cortex blocks memory expression, and AMPA reverses the effect. Pharmacol. Biochem. Behav. 48: 437-440.
96. Rammes, G., Swandulla, D., Spielmanns, P., and Parsons, C.G. 1998. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: Experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology 37: 1299-1320.
97. Rickard, N.S., Poot, A.C., Gibbs, M.E., and Ng, K.T. 1994. Both non-NMDA and NMDA glutamate receptors are necessary for memory consolidation in the day-old chick. Behav. Neural. Biol. 62: 32-40.
98. Riedel, G., Platt, B., and Micheau, J. 2003. Glutamate receptor function in learning and memory. Behav. Brain Res. 140: 1-47.
99. Rochford, J., Sen, A.P., and Quirion, R. 1996. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J. Pharmacol. Exper. Therapeut. 277: 1267-1275.
100. Roerig, B., Nelson, D.A., and Katz, L.C. 1997. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J. Neurosci. 17: 8353-8362.
101. Rogan, M.T., Staubli, U.V., and LeDoux, J.E. 1997. AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired. J. Neurosci. 17: 5928-5935.
102. Role, L.W. and Berg, D.K. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16: 1077-1085.
103. Rudy, J.W. 1993. Contextual conditioning and auditory cue conditioning dissociate during development. Behav. Neurosci. 107: 887-891.
104. Sang, C.N., Hostetter, M.P., Gracely, R.H., Chappell, A.S., Schoepp, D.D., Lee, G., Whitcup, S., Caruso, R., and Max, M.B. 1998. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 89: 1060-1067.
105. Sato, K., Morimoto, K., Yamada, N., Kuroda, S., and Hayabara, T. 1995. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo. Brain Res. 683: 279-282.
106. Schmajuk, N.A., Lam, Y.W., and Christiansen, B.A. 1994. Latent inhibition of the rat eyeblink response: Effect of hippocampal aspiration lesions. Physiol. Behav. 55: 597-601.
107. Schmajuk, N.A., Christiansen, B., and Cox, L. 2000. Haloperidol reinstates latent inhibition impaired by hippocampal lesions: Data and theory. Behav. Neurosci. 114: 659-670.
108. Sershen, H., Balla, A., Lajtha, A., and Vizi, E.S. 1997. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 77: 121-130.
109. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P., and Honore, T. 1990. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247: 571-574.
110. Sheng, M. and Kim, M.J. 2002. Postsynaptic signaling and plasticity mechanisms. Science 298:776-780.
111. Sorenson, E.M., Shiroyama, T., and Kitai, S.T. 1998. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience 87: 659-673.
112. Stephens, D.N. and Cole, B.J. 1996. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology 126: 249-259.
113. Stiedl, O., Birkenfeld, K., Palve, M., and Spiess, J. 2000. Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav. Brain Res. 116: 157-168.
114. Svendsen, F., Tjolsen, A., Rygh, L.J., and Hole, K. 1999. Expression of long-term potentiation in single wide dynamic range neurons in the rat is sensitive to blockade of glutamate receptors. Neurosci. Lett. 259: 25-28.
115. Swedberg, M.D., Jacobsen, P., and Honore, T. 1995. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX). J. Pharmacol. Exp. Ther. 274: 1113-1121.
116. Tinsley, M.R., Quinn, J.J., and Fanselow, M.S. 2004. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: Comparing pavlovian fear conditioning and inhibitory avoidance. Learn. Mem. 11: 35-42.
117. Utsugisawa, K., Nagane, Y., Obara, D., and Tohgi, H. 2002. Over-expression of α7 nicotinic acetylcholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells. Brain Res. Mol. Brain Res. 106: 88-93.
118. Vaitl, D., Lipp, O., Bauer, U., Schuler, G., Stark, R., Zimmermann, M., and Kirsch, P. 2002. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophr. Res. 55: 147-158.
119. Vianna, M.R., Alonso, M., Viola, H., Quevedo, J., de Paris, F., Furman, M., de Stein, M.L., Medina, J.H., and Izquierdo, I. 2000. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn. Mem. 7: 333-340.
120. Walker, D.L. and Davis, M. 1997. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 17: 9375-9383.
121. Weiner, I. 2003. The "two-headed" latent inhibition model of schizophrenia: Modeling positive and negative symptoms and their treatment. Psychopharmacology 169: 257-297.
122. Willmore, C.B., Bespalov, A.Y., and Beardsley, P.M. 2002. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations. Neurobiol. Learn. Mem. 78: 347-364.
123. Wonnacott, S. 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20: 92-98.
124. Yamazaki, Y., Hamaue, N., and Sumikawa, K. 2002. Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction. Brain Res. 946: 148-152.
125. Yasoshima, Y., Morimoto, T., and Yamamoto, T. 2000. Different disruptive effects on the acquisition and expression of conditioned taste aversion by blockades of amygdalar ionotropic and metabotropic glutamatergic receptor subtypes in rats. Brain Res. 869: 15-24.
126. Zhang, Z.W., Coggan, J.S., and Berg, D.K. 1996. Synaptic currents generated by neuronal acetylcholine receptors sensitive to α-bungarotoxin. Neuron 17: 1231-1240.